• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1,113
103
69
68
65

COUNTRY

63
19
16
10
9

CATEGORIES

  • 88
  • 127
  • 68
  • 74
  • 43
  • 42
  • 20
  • 17
  • 18
  • 22

PRICE

563
809
1,568
2,551

PUBLISHED

78
137
710
2,551

PRODUCT TYPE

2,406
70
61
12
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) -...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United States Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Germany Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML)...

April 2013
FROM
Oropharyngeal Cancer - Pipeline Review, H1 2013 Oropharyngeal Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Oropharyngeal Cancer - Pipeline Review, H1 2013

Oropharyngeal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oropharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

April 2013
FROM
Soft Tissue Sarcoma - Pipeline Review, H1 2013 Soft Tissue Sarcoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Review, H1 2013

Soft Tissue Sarcoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Soft Tissue Sarcoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

April 2013
FROM
Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2013 Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H1 2013

Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Hepatocellular Carcinoma (HCC) - Pipeline Review, H2 2013', provides an overview of...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - France Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML)...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) -...

April 2013
FROM

PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022

PharmaPoint: Chronic Myeloid Leukemia (CML) - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Chronic Myeloid Leukemia (CML) -...

April 2013
FROM
Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2013 Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2013

Metastatic Adenocarcinoma of The Pancreas – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2013', provides an overview of...

April 2013
FROM
Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013 Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2013

Recurrent Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2013',...

April 2013
FROM
Metastatic Ovarian Cancer - Pipeline Review, H1 2013 Metastatic Ovarian Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Ovarian Cancer - Pipeline Review, H1 2013

Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013 Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013

Cutaneous T-Cell Lymphoma – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Neuroendocrine Tumors - Pipeline Review, H1 2013 Neuroendocrine Tumors - Pipeline Review, H1 2013 - Product Thumbnail Image

Neuroendocrine Tumors - Pipeline Review, H1 2013

Neuroendocrine Tumors – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Neuroendocrine Tumors - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

April 2013
FROM
Thymus Cancer - Pipeline Review, H1 2013 Thymus Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Thymus Cancer - Pipeline Review, H1 2013

Thymus Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Thymus Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Metastatic Lung Cancer - Pipeline Review, H1 2013 Metastatic Lung Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Metastatic Lung Cancer - Pipeline Review, H1 2013

'Metastatic Lung Cancer - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Metastatic Lung...

April 2013
FROM
B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013 - Product Thumbnail Image

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013

B-Cell Chronic Lymphocytic Leukemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2013', provides an overview of the indication’s...

April 2013
FROM
Uterine Cancer - Pipeline Review, H1 2013 Uterine Cancer - Pipeline Review, H1 2013 - Product Thumbnail Image

Uterine Cancer - Pipeline Review, H1 2013

Uterine Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Uterine Cancer - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

April 2013
FROM
Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013 Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013 - Product Thumbnail Image

Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013

Waldenstrom Macroglobulinemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Waldenstrom Macroglobulinemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic...

April 2013
FROM
Loading Indicator

Our Clients

Our clients' logos